198 related articles for article (PubMed ID: 36467027)
1. Identification of a novel oxidative stress-related prognostic model in lung adenocarcinoma.
Zhu Y; Tang Q; Cao W; Zhou N; Jin X; Song Z; Zu L; Xu S
Front Pharmacol; 2022; 13():1030062. PubMed ID: 36467027
[No Abstract] [Full Text] [Related]
2. A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma.
Peng H; Li X; Luan Y; Wang C; Wang W
Front Oncol; 2023; 13():1078697. PubMed ID: 36798829
[TBL] [Abstract][Full Text] [Related]
3. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma.
Liu T; Hu A; Chen H; Li Y; Wang Y; Guo Y; Liu T; Zhou J; Li D; Chen Q
Transl Cancer Res; 2023 Oct; 12(10):2613-2628. PubMed ID: 37969376
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
9. A more novel and powerful prognostic gene signature of lung adenocarcinoma determined from the immune cell infiltration landscape.
Ma C; Li F; He Z; Zhao S
Front Surg; 2022; 9():1015263. PubMed ID: 36311939
[TBL] [Abstract][Full Text] [Related]
10. Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.
Yin Z; Zhou M; Liao T; Xu J; Fan J; Deng J; Jin Y
Front Oncol; 2021; 11():673567. PubMed ID: 35083132
[TBL] [Abstract][Full Text] [Related]
11. Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma.
Qian C; Jiang Z; Zhou T; Wu T; Zhang Y; Huang J; Ouyang J; Dong Z; Wu G; Cao J
Front Immunol; 2022; 13():1034992. PubMed ID: 36524130
[TBL] [Abstract][Full Text] [Related]
12. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
13. Predicting Differences in Treatment Response and Survival Time of Lung Adenocarcinoma Patients Based on a Prognostic Risk Model of Glycolysis-Related Genes.
Zhao R; Ding D; Ding Y; Han R; Wang X; Zhu C
Front Genet; 2022; 13():828543. PubMed ID: 35692818
[No Abstract] [Full Text] [Related]
14. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma.
Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X
Front Genet; 2022; 13():975905. PubMed ID: 36313456
[No Abstract] [Full Text] [Related]
15. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma.
Zhang A; Yang J; Ma C; Li F; Luo H
Front Cell Dev Biol; 2021; 9():616271. PubMed ID: 34249899
[TBL] [Abstract][Full Text] [Related]
16. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
Li C; Long Q; Zhang D; Li J; Zhang X
BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
[TBL] [Abstract][Full Text] [Related]
17. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
19. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
Wu C; Rao X; Lin W
Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
[TBL] [Abstract][Full Text] [Related]
20. Significance of Spliceosome-Related Genes in the Prediction of Prognosis and Treatment Strategies for Lung Adenocarcinoma.
Yang Y; Huang T; Fan Y; Lu H; Shao J; Wang Y; Shen A
Biomed Res Int; 2022; 2022():1753563. PubMed ID: 36389112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
